FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Novocol Pharmaceutical of Canada Lidocaine Hydrochloride 2% and Epinephrine Recall

Lidocaine Hydrochloride 2% and Epinephrine 1:100,000 Injection, Rx Only, For Dental Blo…

Novocol Pharmaceutical of Canada

Risk level
Class II
Reported by FDA
Sep 4, 2013
Recall ID
D-923-2013
Check your lot numberHow we source this data

Summary

Novocol Pharmaceutical of Canada recalled Lidocaine Hydrochloride 2% and Epinephrine starting Aug 14, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-923-2013 on Sep 4, 2013. Reason: Subpotent Drug; Two lots of Lidocaine 2% with Epinephrine 1:100,000 Injectable, distributed under the names: Octocaine 100, and 2% Xylocaine Dental, may be subpotent for the epinephrine component. Status: Terminated.

Why it was recalled

Subpotent Drug; Two lots of Lidocaine 2% with Epinephrine 1:100,000 Injectable, distributed under the names: Octocaine 100, and 2% Xylocaine Dental, may be subpotent for the epinephrine component.

Product description

Lidocaine Hydrochloride 2% and Epinephrine 1:100,000 Injection, Rx Only, For Dental Block and Infiltration Only, 50 Cartridges per box - 1.7 mL minimum each, NDC #s: a) Octocaine 100, Mfr'ed for Septodont, Louisville, CO, 80027, by Novocol Pharmaceutical of Canada, Inc., Cambridge, Ontario, Canada N1R6X3, 0362-9023-05; b) Superdent, Dist by: Darby Dental Supply Co., Jericho, NY 11753, Made in Canada, 66467-9730-5; and c) Dist by: IQ Dental, 353 Rt 46 W, Bldg C Unit 120, Fairfield, NJ, 07004, made in Canada, 42756-1030-5; Manufactured by: by Novocol Pharmaceutical of Canada, Inc., Cambridge, Ontario, Canada N1R6X3.

Lot numbers, UPCs & expiration codes

Lot #s: D00290 D, Exp 08/2013; D00205 A, Exp 11/2013

Where it was sold

Nationwide and Canada

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-923-2013
Classification
Class II
Status
Terminated
Recall initiated
Aug 14, 2013
FDA report date
Sep 4, 2013
Quantity
12,497 Boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Novocol Pharmaceutical of Canada

Original FDA data

Every field from FDA enforcement report D-923-2013, exactly as published.

Show all FDA fields
City
Cambridge
Status
Terminated
Country
Canada
Event ID
65979
Address
25 Wolseley Court
Code information
Lot #s: D00290 D, Exp 08/2013; D00205 A, Exp 11/2013
Report date
Sep 4, 2013
Product type
Drugs
Recall number
D-923-2013
Classification
Class II
Recalling firm
Novocol Pharmaceutical of Canada
Product quantity
12,497 Boxes
Termination date
Jan 7, 2014
Reason for recall
Subpotent Drug; Two lots of Lidocaine 2% with Epinephrine 1:100,000 Injectable, distributed under the names: Octocaine 100, and 2% Xylocaine Dental, may be subpotent for the epinephrine component.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine Hydrochloride 2% and Epinephrine 1:100,000 Injection, Rx Only, For Dental Block and Infiltration Only, 50 Cartridges per box - 1.7 mL minimum each, NDC #s: a) Octocaine 100, Mfr'ed for Septodont, Louisville, CO, 80027, by Novocol Pharmaceutical of Canada, Inc., Cambridge, Ontario, Canada N1R6X3, 0362-9023-05; b) Superdent, Dist by: Darby Dental Supply Co., Jericho, NY 11753, Made in Canada, 66467-9730-5; and c) Dist by: IQ Dental, 353 Rt 46 W, Bldg C Unit 120, Fairfield, NJ, 07004, made in Canada, 42756-1030-5; Manufactured by: by Novocol Pharmaceutical of Canada, Inc., Cambridge, Ontario, Canada N1R6X3.
Distribution pattern
Nationwide and Canada
Recall initiation date
Aug 14, 2013
Initial firm notification
E-Mail
Center classification date
Aug 26, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-923-2013, published Sep 4, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls